Silvia Rota

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Nirosen Vijiaratnam, Christine Girges, Grace Auld et al. · The Lancet · 2025 · 83 citations · Full text

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Lucia Batzu, Silvia Rota, Abdul Hye et al. · npj Parkinson s Disease · 2022 · 58 citations · Full text

Non-muscle involvement in late-onset glycogenosis II.

Massimiliano Filosto, Alice Todeschini, Maria Sofia Cotelli et al. · Europe PMC (PubMed Central) · 2013 · 25 citations

Metabolic Disorder, Glycobiology, Immunology +16

ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study

Massimiliano Filosto, Massimo Aureli, Barbara Castellotti et al. · European Journal of Human Genetics · 2016 · 23 citations · Full text

Clinical Disorders, Mendelian Disorder, Neurological Disorder +10

Self-reported periodontitis and C-reactive protein in Parkinson’s disease: a cross-sectional study of two American cohorts

Patrícia Lyra, João Botelho, Vanessa Machado et al. · npj Parkinson s Disease · 2022 · 21 citations · Full text